Company News

Home » Blog » Company News

HKeybio Participare in BIO CHINA 2024
2024-04-09

Suzhou, Sina - HKeybio, prima societas biotechnologiae specialiter in auotimmune morborum exemplorum, excitatur ad nuntiandum eius participationem in venturo BIO Sinarum Conferentiarum horarum a die 14 Martii usque ad 16, 2024. Colloquium Suzhou Internationalis Expo Centre habendum est, wi Read More
BIO EUROPE 2023| Auxilium HKeybio Intra forum Internationale
2024-04-09

BIO-Europe 2023 die 6 Novembris 6-8, Munich 2023, in Germania, magnifice aperta est. BIO-Europe iamdiu centrum innovationis in sectoribus biotechicis, pharmaceuticis, et oeconomicis fuit. Eventus quotannis in alia urbe colitur, aedificans retis medicinae professionalium validam ex plusquam 60 comite Read More
HKeybio communicare in MMXXIV BIO
2024-04-09

San Diego, California, 2024 - HKeybio, prima societas biotechnologiae specialiter in morbis autoimmunes, eius participationem nuntiat in ventura 2024 BIO et Exhibitio in Civitatibus Foederatis Americae. Read More

Summa 3 paginarum Go to Page
Go

HKeybio est Contractio Research Organizationis (CRO) specialis in investigationibus preclinicis intra campum morborum autoimmunerum.

Velox Vincula

Service Catagory

Contact Us

Negotium Procurator-Julie Lu：+86- 18662276408
Negotium Inquisitionis-Will Yang：+86- 17519413072
Consultatio Technical-Evan Liu：+86- 17826859169

info@hkeybio.com; tech@hkeybio.com;

nobis. bd@hkeybio.com; feugiat. bd@hkeybio.com; uk. bd@hkeybio.com .
: Aedificium B, No.388 Xingping Street, Ascendas iHub Suzhou Industrial Park, JIANGSU, CHINA

Aliquam Nuntius

Subcribo sursum pro nostro tabellario ad novissimum nuntium recipiendum.